Nevertheless, in the past 2 years, it has become clear that Rab25 overexpression in breast cancer is likely less common and that indeed, at least in oestrogen receptor-deficient cancers, expression is actually decreased significantly (Cheng et al, 2006, 2010). This evidence concerns the gene RAB25 and cancer.